Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
life sciences
national blog main
biotech
boston blog main
boston top stories
fda
national top stories
achromatopsia
beta-thalassemia
bill cassidy
biopharma
bluebird bio
boston
clinical trials
dna
duchenne
europe blog main
europe top stories
food and drug administration
gene therapy
harvard pilgrim health care
hemophilia
johnson & johnson
licensing
luxturna
m&a
mark warner
mathai mammen
medicaid
medical device
meiragtx
muscular dystrophy
new york
new york blog main
new york top stories
novartis
patient affordability value and efficiency act
pulmonary arterial hypertension
raleigh-durham blog main
What
deal
3
×
therapy
3
×
gene
therapeutics
age
approval
betting
bigger
biggest
billion
biopharma
building
come
developer
disease
drug
duchenne
emerging
established
fda
firm
gave
historic
j
johnson
lung
medicine
meiragtx
momentum
morning
pah
past
puts
rare
reaches
recently
rivalry
rna
roche
sarepta
Language
unset
Current search:
deal
×
therapy
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed